SPHD vs XBI
Invesco S&P 500 High Dividend Low Volatility ETF vs SPDR S&P Biotech ETF
- • SPHD has the lower expense ratio at 0.30% vs 0.35% for XBI.
- • SPHD pays a higher dividend yield (4.58%).
Side-by-side metrics
| Metric | SPHD | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.30% | 0.35% |
Dividend yield Trailing 12-month yield. | 4.58% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $3.31B | $10.73B |
YTD return | 10.15% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.47 | 1.10 |
P/E ratio | 17.55 | — |
Last price | $51.60 | $164.01 |
Inception | — | — |
Issuer | Invesco | State Street |
SPHD top holdings
| DOC | Healthpeak Properties Inc | 3.68% |
| MO | Altria Group Inc | 3.62% |
| VZ | Verizon Communications Inc | 3.14% |
| BEN | Franklin Resources Inc | 3.07% |
| KHC | The Kraft Heinz Co | 3.03% |
| OKE | ONEOK Inc | 2.80% |
| PFE | Pfizer Inc | 2.79% |
| AMCR | Amcor PLC Ordinary Shares | 2.73% |
| KIM | Kimco Realty Corp | 2.63% |
| VICI | VICI Properties Inc Ordinary Shares | 2.55% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About SPHD
SPHD (Invesco S&P 500 High Dividend Low Volatility ETF) is High-yield, low-volatility S&P 500 stocks. Managed by Invesco, the fund carries $3.3B in assets under management, an expense ratio of 0.30%, a dividend yield of 4.58%. Its largest holding is Healthpeak Properties Inc (DOC), which represents 3.7% of the portfolio. Real Estate is the fund's largest sector exposure at 22.1%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.